Meningococcal B

Meningococcal Serogroup B  (aka Trumenba or Bexsero)

Recommended between 16 to 18 years of age

10+ yearsIf local outbreak; absent or damaged spleen; complement deficiency

16-18 years  Second dose 6 months after first dose